The Sponsor is conducting a survey to understand how parents or legal guardians feel about the benefits of using the Precice IMLL System to lengthen limbs in children who are 12 years old or younger.
All participants in this survey study will be the parent or legal guardian of a child who previously underwent surgery for limb length discrepancy according to the practitioner's standard of care, was 12 years of age or younger at the time of surgery, and is enrolled in the Precice IMLL arm in protocol NUVA.IMLL0723. The parent or legal guardian will be familiar with the patient's preoperative and postoperative condition, surgical treatment, postoperative care, and clinical outcomes. Each parent or legal guardian will complete the perceived clinical benefits survey questionnaire once. The survey will be administered as either a paper-based questionnaire via mail or over the phone or an electronic questionnaire completed via a secure online application.
Study Type
OBSERVATIONAL
Enrollment
100
Parents or legal guardians of children that previously received the Precice IMLL will complete a survey. No additional or new interventions will be administered.
Paley Orthopedic and Spine Institute
West Palm Beach, Florida, United States
Nationwide Childrens Hospital
Columbus, Ohio, United States
Perceived clinical benefits of the Precice Intramedullary Limb Lengthening (IMLL) Survey System
Non-validated survey to assess the perceived clinical benefits of the Precice Intramedullary Limb Lengthening (IMLL) System in limb lengthening procedures in pediatric patients ages 12 years and younger as reported by parents or legal guardians.
Time frame: 1 year post-op
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.